Editing Cancer (TRPM7)

{{tp|p=30338939|t=2018. Prostaglandin E2 increases migration and proliferation of human glioblastoma cells by activating transient receptor potential melastatin 7 channels.|pdf=|usr=}}{{30338939}}
{{tp|p=22355351|t=2012. Kinome-wide functional genomics screen reveals a novel mechanism of TNFalpha-induced nuclear accumulation of the HIF-1alpha transcription factor in cancer cells.|pdf=|usr=}}{{22355351}}
{{tp|p=38156103|t=2023. OIP5-AS1/CD147/TRPM7 axis promotes gastric cancer metastasis by regulating apoptosis related PI3K-Akt signaling.|pdf=|usr=}}{{38156103}}
{{tp|p=37839677|t=2023. Roles of TRPM7 in ovarian cancer.|pdf=|usr=}}{{37839677}}
{{tp|p=37642779|t=2023. TRPM7 transactivates the FOSL1 gene through STAT3 and enhances glioma stemness.|pdf=|usr=}}{{37642779}}
{{tp|p=37507867|t=2023. TRP Channels in Tumoral Processes Mediated by Oxidative Stress and Inflammation.|pdf=|usr=}}{{37507867}}
{{tp|p=36878949|t=2023. The TRPM7 channel reprograms cellular glycolysis to drive tumorigenesis and angiogenesis.|pdf=|usr=}}{{36878949}}
{{tp|p=36818331|t=2023. Cardiovascular toxicity of tyrosine kinase inhibitors during cancer treatment: Potential involvement of TRPM7.|pdf=|usr=}}{{36818331}}
{{tp|p=36363540|t=2022. Clinical and Prognostic Values of TRPM7 in Colon and Rectal Cancers.|pdf=|usr=}}{{36363540}}
{{tp|p=36064388|t=2022. Promoter methylation of transient receptor potential melastatin-related 7 (TRPM7) predicts a better prognosis in patients with Luminal A breast cancers.|pdf=|usr=}}{{36064388}}
{{tp|p=35771152|t=2022. TRPM7 via calcineurin/NFAT pathway mediates metastasis and chemotherapeutic resistance in head and neck squamous cell carcinoma.|pdf=|usr=}}{{35771152}}
{{tp|p=35711942|t=2022. Differential Expression of Genes Regulating Store-operated Calcium Entry in Conjunction With Mitochondrial Dynamics as Potential Biomarkers for Cancer: A Single-Cell RNA Analysis.|pdf=|usr=}}{{35711942}}
{{tp|p=35242236|t=2022. Transient receptor potential channels in multiple myeloma.|pdf=|usr=}}{{35242236}}
{{tp|p=35101076|t=2022. TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1alpha degradation.|pdf=|usr=}}{{35101076}}
{{tp|p=34944940|t=2021. TRPM7 Ion Channel: Oncogenic Roles and Therapeutic Potential in Breast Cancer.|pdf=|usr=}}{{34944940}}
{{tp|p=34938330|t=2021. Prognostic Value of TRPM7 Expression and Factor XIIIa-Expressing Tumor-Associated Macrophages in Gastric Cancer.|pdf=|usr=}}{{34938330}}
{{tp|p=34901284|t=2021. hsa_circ_0023305 Enhances Laryngeal Squamous Cell Carcinoma Progression and Modulates TRPM7 via miR-218-5p Sponging.|pdf=|usr=}}{{34901284}}
{{tp|p=34285910|t=2021. Oridonin Promotes Apoptosis and Restrains the Viability and Migration of Bladder Cancer by Impeding TRPM7 Expression via the ERK and AKT Signaling Pathways.|pdf=|usr=}}{{34285910}}
{{tp|p=34244134|t=2021. The fluid shear stress sensor TRPM7 regulates tumor cell intravasation.|pdf=|usr=}}{{34244134}}
{{tp|p=34042256|t=2021. Tumor suppressor miR-192-5p targets TRPM7 and inhibits proliferation and invasion in cervical cancer.|pdf=|usr=}}{{34042256}}
{{tp|p=33891828|t=2021. Leptin Induces Epigenetic Regulation of Transient Receptor Potential Melastatin 7 in Rat Adrenal Pheochromocytoma Cells.|pdf=|usr=}}{{33891828}}
{{tp|p=33617107|t=2021. Expression and prognostic value of TRPM7 in canine mammary tumours.|pdf=|usr=}}{{33617107}}
{{tp|p=33435261|t=2021. Lidocaine Suppresses Viability and Migration of Human Breast Cancer Cells: TRPM7 as a Target for Some Breast Cancer Cell Lines.|pdf=|usr=}}{{33435261}}
{{tp|p=33381038|t=2020. TRPM7 Induces Tumorigenesis and Stemness Through Notch Activation in Glioma.|pdf=|usr=}}{{33381038}}
{{tp|p=33310045|t=2021. Carvacrol affects breast cancer cells through TRPM7 mediated cell cycle regulation.|pdf=|usr=}}{{33310045}}
{{tp|p=37495546|t=2023. Sinomenine regulates circTRPM7-related pathway to inhibit gastric cancer cell growth and metastasis.|pdf=|usr=}}{{37495546}}
{{tp|p=36332746|t=2022. A pan-cancer-bioinformatic-based literature review of TRPM7 in cancers.|pdf=|usr=}}{{36332746}}
{{tp|p=34958137|t=2022. Suppression of transient receptor potential melastatin 7 regulates pluripotency, proliferation, and differentiation of mouse embryonic stem cells via mechanistic target of rapamycin-extracellular signal-regulated kinase activation.|pdf=|usr=}}{{34958137}}
{{tp|p=34953296|t=2022. Modulators of TRPM7 and its potential as a drug target for brain tumours.|pdf=|usr=}}{{34953296}}
{{tp|p=34752845|t=2022. Stimulating TRPM7 suppresses cancer cell proliferation and metastasis by inhibiting autophagy.|pdf=|usr=}}{{34752845}}
{{tp|p=33784560|t=2021. Role of TRPM7 kinase in cancer.|pdf=|usr=}}{{33784560}}
{{tp|p=33080445|t=2020. Inhibition of TRPM7 with waixenicin A reduces glioblastoma cellular functions.|pdf=|usr=}}{{33080445}}
{{tp|p=32505565|t=2020. TRPM7 is overexpressed in human IBD-related and sporadic colorectal cancer and correlates with tumor grade.|pdf=|usr=}}{{32505565}}
{{tp|p=32468675|t=2020. Suppression of TRPM7 enhances TRAIL-induced apoptosis in triple-negative breast cancer cells.|pdf=|usr=}}{{32468675}}
{{tp|p=31844251|t=2020. Inhibition of TRPM7 blocks MRTF/SRF-dependent transcriptional and tumorigenic activity.|pdf=|usr=}}{{31844251}}
{{tp|p=31640089|t=2019. TRPM7 deficiency suppresses cell proliferation, migration, and invasion in human colorectal cancer via regulation of epithelial-mesenchymal transition.|pdf=|usr=}}{{31640089}}
{{tp|p=30710498|t=2019. miR-543 inhibites cervical cancer growth and metastasis by targeting TRPM7.|pdf=|usr=}}{{30710498}}
{{tp|p=30513244|t=2019. Effects of Salivary Mg on Head and Neck Carcinoma via TRPM7.|pdf=|usr=}}{{30513244}}
{{tp|p=29545479|t=2018. TRPM7 Regulates AKT/FOXO1-Dependent Tumor Growth and Is an Independent Prognostic Indicator in Renal Cell Carcinoma.|pdf=|usr=}}{{29545479}}
{{tp|p=32907556|t=2020. Knockdown of TRPM7 prevents tumor growth, migration, and invasion through the Src, Akt, and JNK pathway in bladder cancer.|pdf=|usr=}}{{32907556}}
{{tp|p=32801754|t=2020. Long Noncoding RNA ST7-AS1 Upregulates TRPM7 Expression by Sponging microRNA-543 to Promote Cervical Cancer Progression.|pdf=|usr=}}{{32801754}}
{{tp|p=32733880|t=2020. TRPM7/RPSA Complex Regulates Pancreatic Cancer Cell Migration.|pdf=|usr=}}{{32733880}}
{{tp|p=32684624|t=2020. A novel TRPM7/O-GlcNAc axis mediates tumour cell motility and metastasis by stabilising c-Myc and caveolin-1 in lung carcinoma.|pdf=|usr=}}{{32684624}}
{{tp|p=32390858|t=2020. Isoproterenol-Dependent Activation of TRPM7 Protects Against Neurotoxin-Induced Loss of Neuroblastoma Cells.|pdf=|usr=}}{{32390858}}
{{tp|p=32215176|t=2020. Suppression of TRPM7 Inhibited Hypoxia-Induced Migration and Invasion of Androgen-Independent Prostate Cancer Cells by Enhancing RACK1-Mediated Degradation of HIF-1alpha.|pdf=|usr=}}{{32215176}}
{{tp|p=31947967|t=2020. The Role of Transient Receptor Potential Melastatin 7 (TRPM7) in Cell Viability: A Potential Target to Suppress Breast Cancer Cell Cycle.|pdf=|usr=}}{{31947967}}
{{tp|p=31921670|t=2019. TRPM7 Induces Mechanistic Target of Rap1b Through the Downregulation of miR-28-5p in Glioma Proliferation and Invasion.|pdf=|usr=}}{{31921670}}
{{tp|p=31636470|t=2019. Role of ion channels in gastrointestinal cancer.|pdf=|usr=}}{{31636470}}
{{tp|p=31293101|t=2019. TRPM7 is involved in acid-induced necrotic cell death in a manner sensitive to progesterone in human cervical cancer cells.|pdf=|usr=}}{{31293101}}
{{tp|p=30279961|t=2018. The vesicular transfer of CLIC1 from glioblastoma to microvascular endothelial cells requires TRPM7.|pdf=|usr=}}{{30279961}}
{{tp|p=29984342|t=2018. Down-regulation of transient receptor potential melastatin member 7 prevents migration and invasion of renal cell carcinoma cells via inactivation of the Src and Akt pathway.|pdf=|usr=}}{{29984342}}
{{tp|p=29875336|t=2018. TRPM Family Channels in Cancer.|pdf=|usr=}}{{29875336}}
{{tp|p=29684587|t=2018. TRPM7 controls mesenchymal features of breast cancer cells by tensional regulation of SOX4.|pdf=|usr=}}{{29684587}}
{{tp|p=28810912|t=2017. Inhibition of TRPM7 suppresses cell proliferation of colon adenocarcinoma in vitro and induces hypomagnesemia in vivo without affecting azoxymethane-induced early colon cancer in mice.|pdf=|usr=}}{{28810912}}
{{tp|p=28791418|t=2017. TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth.|pdf=|usr=}}{{28791418}}
{{tp|p=28533887|t=2017. Lidocaine suppresses glioma cell proliferation by inhibiting TRPM7 channels.|pdf=|usr=}}{{28533887}}
{{tp|p=28462107|t=2016. Role of transient receptor potential melastatin type 7 channel in gastric cancer.|pdf=|usr=}}{{28462107}}
{{tp|p=28314277|t=2017. Transient Receptor Potential Melastatin 7 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma.|pdf=|usr=}}{{28314277}}
{{tp|p=28161478|t=2017. Identification of TG100-115 as a new and potent TRPM7 kinase inhibitor, which suppresses breast cancer cell migration and invasion.|pdf=|usr=}}{{28161478}}
{{tp|p=27693494|t=2016. Bradykinin promotes migration and invasion of hepatocellular carcinoma cells through TRPM7 and MMP2.|pdf=|usr=}}{{27693494}}
{{tp|p=27629139|t=2016. TRPM7 channel inhibition mediates midazolam-induced proliferation loss in human malignant glioma.|pdf=|usr=}}{{27629139}}
{{tp|p=27604090|t=2016. Recent Advances in Oncogenic Roles of the TRPM7 Chanzyme.|pdf=|usr=}}{{27604090}}
{{tp|p=27402209|t=2016. The TRPM7 interactome defines a cytoskeletal complex linked to neuroblastoma progression.|pdf=|usr=}}{{27402209}}
{{tp|p=26918850|t=2016. Magnesium Modulates Doxorubicin Activity through Drug Lysosomal Sequestration and Trafficking.|pdf=|usr=}}{{26918850}}
{{tp|p=26779625|t=2016. Functional characterization of TRPM7 in nasopharyngeal carcinoma and its knockdown effects on tumorigenesis.|pdf=|usr=}}{{26779625}}
{{tp|p=26088448|t=2015. Gene expressions of TRP channels in glioblastoma multiforme and relation with survival.|pdf=|usr=}}{{26088448}}
{{tp|p=25450691|t=2014. TRPM7 is required for ovarian cancer cell growth, migration and invasion.|pdf=|usr=}}{{25450691}}
{{tp|p=25304381|t=2015. TRPM7 promotes the metastatic process in human nasopharyngeal carcinoma.|pdf=|usr=}}{{25304381}}
{{tp|p=25069584|t=2014. Oncogenic role and therapeutic target of transient receptor potential melastatin 7 channel in malignancy.|pdf=|usr=}}{{25069584}}
{{tp|p=28410232|t=2017. Vacquinol-1 inducible cell death in glioblastoma multiforme is counter regulated by TRPM7 activity induced by exogenous ATP.|pdf=|usr=}}{{28410232}}
{{tp|p=28379203|t=2017. Role of TRPM7 in Cancer: Potential as Molecular Biomarker and Therapeutic Target.|pdf=|usr=}}{{28379203}}
{{tp|p=28284058|t=2017. The Transient Receptor Potential Melastatin 7 Channel Regulates Pancreatic Cancer Cell Invasion through the Hsp90alpha/uPA/MMP2 pathway.|pdf=|usr=}}{{28284058}}
{{tp|p=28101241|t=2016. Potential role of melastatin-related transient receptor potential cation channel subfamily M gene expression in the pathogenesis of urinary bladder cancer.|pdf=|usr=}}{{28101241}}
{{tp|p=28094304|t=2017. The different expression of TRPM7 and MagT1 impacts on the proliferation of colon carcinoma cells sensitive or resistant to doxorubicin.|pdf=|usr=}}{{28094304}}
{{tp|p=28061441|t=2017. Activation of TRPM7 by naltriben enhances migration and invasion of glioblastoma cells.|pdf=|usr=}}{{28061441}}
{{tp|p=27803760|t=2016. Carvacrol Alleviates Prostate Cancer Cell Proliferation, Migration, and Invasion through Regulation of PI3K/Akt and MAPK Signaling Pathways.|pdf=|usr=}}{{27803760}}
{{tp|p=27662662|t=2016. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.|pdf=|usr=}}{{27662662}}
{{tp|p=27185858|t=2016. TRPM7 is a molecular substrate of ATP-evoked P2X7-like currents in tumor cells.|pdf=|usr=}}{{27185858}}
{{tp|p=26703785|t=2016. Quantitative imaging of magnesium distribution at single-cell resolution in brain tumors and infiltrating tumor cells with secondary ion mass spectrometry (SIMS).|pdf=|usr=}}{{26703785}}
{{tp|p=26563869|t=2015. Magnesium homeostasis in colon carcinoma LoVo cells sensitive or resistant to doxorubicin.|pdf=|usr=}}{{26563869}}
{{tp|p=15286426|t=2004. Involvement of TRPM7 in cell growth as a spontaneously activated Ca2+ entry pathway in human retinoblastoma cells.|pdf=|usr=}}{{15286426}}
{{tp|p=23910495|t=2013. Transient receptor potential melastatin 7 is involved in oestrogen receptor-negative metastatic breast cancer cells migration through its kinase domain.|pdf=|usr=}}{{23910495}}
{{tp|p=23353055|t=2013. TRPM7 mediates breast cancer cell migration and invasion through the MAPK pathway.|pdf=|usr=}}{{23353055}}
{{tp|p=22671428|t=2012. Magnesium and its transporters in cancer: a novel paradigm in tumour development.|pdf=|usr=}}{{22671428}}
{{tp|p=22308955|t=2012. The role of transient receptor potential channel blockers in human gastric cancer cell viability.|pdf=|usr=}}{{22308955}}
{{tp|p=21978419|t=2011. EGF enhances the migration of cancer cells by up-regulation of TRPM7.|pdf=|usr=}}{{21978419}}
{{tp|p=20363498|t=2010. TRPM7 regulates the migration of human nasopharyngeal carcinoma cell by mediating Ca(2+) influx.|pdf=|usr=}}{{20363498}}
{{tp|p=18826101|t=2008. [Transient receptor potential melastatin 7 channel protein in human head and neck carcinoma cells and role in cell proliferation].|pdf=|usr=}}{{18826101}}
{{tp|p=25965832|t=2015. Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion.|pdf=|usr=}}{{25965832}}
{{tp|p=25913706|t=2015. Xyloketal B suppresses glioblastoma cell proliferation and migration in vitro through inhibiting TRPM7-regulated PI3K/Akt and MEK/ERK signaling pathways.|pdf=|usr=}}{{25913706}}
{{tp|p=25797249|t=2015. TRPM7 maintains progenitor-like features of neuroblastoma cells: implications for metastasis formation.|pdf=|usr=}}{{25797249}}
{{tp|p=25770184|t=2015. Aberrant over-expression of TRPM7 ion channels in pancreatic cancer: required for cancer cell invasion and implicated in tumor growth and metastasis.|pdf=|usr=}}{{25770184}}
{{tp|p=25438992|t=2015. Suppression of TRPM7 inhibits proliferation, migration, and invasion of malignant human glioma cells.|pdf=|usr=}}{{25438992}}
{{tp|p=25426416|t=2014. MycN promotes TRPM7 expression and cell migration in neuroblastoma through a process that involves polyamines.|pdf=|usr=}}{{25426416}}
{{tp|p=25367030|t=2014. TRPM7 involvement in cancer: a potential prognostic factor.|pdf=|usr=}}{{25367030}}
{{tp|p=25277194|t=2014. N-Myc-induced up-regulation of TRPM6/TRPM7 channels promotes neuroblastoma cell proliferation.|pdf=|usr=}}{{25277194}}
{{tp|p=25192910|t=2014. TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways.|pdf=|usr=}}{{25192910}}
{{tp|p=24952306|t=2014. The association between single-nucleotide polymorphisms of TRPM7 gene and breast cancer in Han Population of Northeast China.|pdf=|usr=}}{{24952306}}
{{tp|p=24935580|t=2014. Overexpression of TRPM7 is associated with poor prognosis in human ovarian carcinoma.|pdf=|usr=}}{{24935580}}
{{tp|p=24849279|t=2014. Potential role of transient receptor potential (TRP) channels in bladder cancer cells.|pdf=|usr=}}{{24849279}}
{{tp|p=24556627|t=2013. From magnesium to magnesium transporters in cancer: TRPM7, a novel signature in tumour development.|pdf=|usr=}}{{24556627}}
{{tp|p=24176224|t=2013. TRPM7 triggers Ca2+ sparks and invadosome formation in neuroblastoma cells.|pdf=|usr=}}{{24176224}}
{{tp|p=23686305|t=2014. Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent.|pdf=|usr=}}{{23686305}}
{{tp|p=23662076|t=2012. Serum calcium levels, TRPM7, TRPC1, microcalcifications, and breast cancer using breast imaging reporting and data system scores.|pdf=|usr=}}{{23662076}}
{{tp|p=23594099|t=2013. Remodeling of calcium signaling in tumor progression.|pdf=|usr=}}{{23594099}}
{{tp|p=23168410|t=2013. Increase in serum Ca2+/Mg2+ ratio promotes proliferation of prostate cancer cells by activating TRPM7 channels.|pdf=|usr=}}{{23168410}}
{{tp|p=25780645|t=2012. Involvement of Transient Receptor Potential Melastatin 7 Channels in Sophorae Radix-induced Apoptosis in Cancer Cells: Sophorae Radix and TRPM7.|pdf=|usr=}}{{25780645}}
{{tp|p=22897572|t=2012. Role of TRPM in melanocytes and melanoma.|pdf=|usr=}}{{22897572}}
{{tp|p=22871386|t=2012. TRPM7 is required for breast tumor cell metastasis.|pdf=|usr=}}{{22871386}}
{{tp|p=22640890|t=2012. Canaux cationiques TRP dans le cancer du sein : expression, role et correlation avec des parametres cliniques.|pdf=|usr=}}{{22640890}}
{{tp|p=22323115|t=2012. Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cell migration.|pdf=|usr=}}{{22323115}}
{{tp|p=24278689|t=2012. TRPM7 and TRPM8 Ion Channels in Pancreatic Adenocarcinoma: Potential Roles as Cancer Biomarkers and Targets.|pdf=|usr=}}{{24278689}}
{{tp|p=22178934|t=2011. High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters.|pdf=|usr=}}{{22178934}}
{{tp|p=22166235|t=2012. Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma.|pdf=|usr=}}{{22166235}}
{{tp|p=21183474|t=2011. Transient receptor potential ion channel Trpm7 regulates exocrine pancreatic epithelial proliferation by Mg2+-sensitive Socs3a signaling in development and cancer.|pdf=|usr=}}{{21183474}}
{{tp|p=19515901|t=2009. Evidence that TRPM7 is required for breast cancer cell proliferation.|pdf=|usr=}}{{19515901}}
{{tp|p=19032368|t=2008. Suppression of transient receptor potential melastatin 7 channel induces cell death in gastric cancer.|pdf=|usr=}}{{19032368}}
{{tp|p=18006838|t=2007. Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation.|pdf=|usr=}}{{18006838}}
{{tp|p=17823441|t=2007. The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk.|pdf=|usr=}}{{17823441}}
{{tp|p=17632567|t=2007. TRP-ing up melanophores: TRPM7, melanin synthesis, and pigment cell survival.|pdf=|usr=}}{{17632567}}
{{tp|p=34950031|t=2021. Mechanisms of Cancer Inhibition by Local Anesthetics.|pdf=|usr=}}{{34950031}}
{{tp|p=31801263|t=2019. Transient Receptor Potential Cation Channels in Cancer Therapy.|pdf=|usr=}}{{31801263}}
{{tp|p=17290233|t=2007. Cell death of melanophores in zebrafish trpm7 mutant embryos depends on melanin synthesis.|pdf=|usr=}}{{17290233}}
{{ttp|p=36006540|t=2023. The Supplement of Magnesium Element to Inhibit Colorectal Tumor Cells.|pdf=|usr=}}{{36006540}}
{{ttp|p=35600975|t=2023. Mg-based materials diminish tumor spreading and cancer metastases.|pdf=|usr=}}{{35600975}}
{{tp|p=35454136|t=2022. Transient Receptor Potential (TRP) Channels: Markers and Therapeutic Targets for Cancer?|pdf=|usr=}}{{35454136}}
{{tp|p=34065398|t=2021. Transient Receptor Potential (TRP) Channels in Haematological Malignancies: An Update.|pdf=|usr=}}{{34065398}}
{{tp|p=32887220|t=2020. pH-Channeling in Cancer: How pH-Dependence of Cation Channels Shapes Cancer Pathophysiology.|pdf=|usr=}}{{32887220}}
{{tp|p=32172727|t=2020. Emerging role of transient receptor potential (TRP) channels in cancer progression.|pdf=|usr=}}{{32172727}}
{{tp|p=30876463|t=2019. Lidocaine inhibits growth, migration and invasion of gastric carcinoma cells by up-regulation of miR-145.|pdf=|usr=}}{{30876463}}
{{tp|p=29186827|t=2017. Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer.|pdf=|usr=}}{{29186827}}
{{tp|p=28284204|t=2017. Calcium - Magnesium imbalance implicated in benign prostatic hyperplasia and restoration by a phytotherapeutic drug - Croton membranaceus Mull.Arg.|pdf=|usr=}}{{28284204}}
{{tp|p=24724725|t=2014. TRP channels and STIM/ORAI proteins: sensors and effectors of cancer and stroma cell migration.|pdf=|usr=}}{{24724725}}
{{tp|p=36844925|t=2022. On the modulation of TRPM channels: Current perspectives and anticancer therapeutic implications.|pdf=|usr=}}{{36844925}}
{{tp|p=36186485|t=2022. Development and validation of a TRP-related gene signature for overall survival prediction in lung adenocarcinoma.|pdf=|usr=}}{{36186485}}
{{tp|p=34408981|t=2021. Perioperative Intravenous Lidocaine and Metastatic Cancer Recurrence - A Narrative Review.|pdf=|usr=}}{{34408981}}
{{tp|p=34178620|t=2021. TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer.|pdf=|usr=}}{{34178620}}
{{tp|p=33928077|t=2021. TRP Channels in Brain Tumors.|pdf=|usr=}}{{33928077}}
{{tp|p=33923883|t=2021. Imbalance of Mg Homeostasis as a Potential Biomarker in Colon Cancer.|pdf=|usr=}}{{33923883}}
{{tp|p=33163084|t=2020. Carvacrol: An In Silico Approach of a Candidate Drug on HER2, PI3Kalpha, mTOR, hER-alpha, PR, and EGFR Receptors in the Breast Cancer.|pdf=|usr=}}{{33163084}}
{{tp|p=32766241|t=2020. Repositioning Lidocaine as an Anticancer Drug: The Role Beyond Anesthesia.|pdf=|usr=}}{{32766241}}
{{tp|p=32742323|t=2020. Evaluation of the TRPM protein family as potential biomarkers for various types of human cancer using public database analyses.|pdf=|usr=}}{{32742323}}
{{tp|p=28706559|t=2017. Insights into the Roles of Midazolam in Cancer Therapy.|pdf=|usr=}}{{28706559}}
{{tp|p=25852478|t=2015. Cancer as a channelopathy: ion channels and pumps in tumor development and progression.|pdf=|usr=}}{{25852478}}
{{tp|p=37501216|t=2023. A narrative review on the role of magnesium in immune regulation, inflammation, infectious diseases, and cancer.|pdf=|usr=}}{{37501216}} 
{{tp|p=36430727|t=2022. Transient Receptor Potential (TRP) Channels in Tumor Vascularization.|pdf=|usr=}}{{36430727}}
{{tp|p=36012311|t=2022. The Association between TRP Channels Expression and Clinicopathological Characteristics of Patients with Pancreatic Adenocarcinoma.|pdf=|usr=}}{{36012311}}
{{tp|p=34950031|t=2021. Mechanisms of Cancer Inhibition by Local Anesthetics.|pdf=|usr=}}{{34950031}}
{{tp|p=34305611|t=2021. Antitumor Effects of Carvacrol and Thymol: A Systematic Review.|pdf=|usr=}}{{34305611}}
{{tp|p=32182937|t=2020. TRP Channels in Digestive Tract Cancers.|pdf=|usr=}}{{32182937}}
{{tp|p=31110973|t=2019. Tissue and Serum Trace Elements Concentration among Colorectal Patients: A Systematic Review of Case-Control Studies.|pdf=|usr=}}{{31110973}}
{{tp|p=28448473|t=2017. Transcriptomic Analysis of Calcium Remodeling in Colorectal Cancer.|pdf=|usr=}}{{28448473}}
{{tp|p=27618016|t=2016. Ion Channels in Brain Metastasis.|pdf=|usr=}}{{27618016}}
{{tp|p=25347473|t=2014. Membrane protein CNNM4-dependent Mg2+ efflux suppresses tumor progression.|pdf=|usr=}}{{25347473}}
{{tp|p=36983900|t=2023. Attenuation of Endoplasmic Reticulum Stress Enhances Carvacrol-Induced Apoptosis in Osteosarcoma Cell Lines.|pdf=|usr=}}{{36983900}}
{{tp|p=36837670|t=2023. Mechanosensitive Ion Channels and Their Role in Cancer Cells.|pdf=|usr=}}{{36837670}}
{{tp|p=36658649|t=2023. Metal ions and nanometallic materials in antitumor immunity: Function, application, and perspective.|pdf=|usr=}}{{36658649}}
{{tp|p=35614079|t=2022. Pan-cancer analyses reveal the genetic and pharmacogenomic landscape of transient receptor potential channels.|pdf=|usr=}}{{35614079}}
{{tp|p=34704011|t=2021. Biofunctional magnesium-coated Ti6Al4V scaffolds promote autophagy-dependent apoptosis in osteosarcoma by activating the AMPK/mTOR/ULK1 signaling pathway.|pdf=|usr=}}{{34704011}}
{{tp|p=35368816|t=2021. Hypomagnesemia in the Cancer Patient.|pdf=|usr=}}{{35368816}}
{{tp|p=31801263|t=2019. Transient Receptor Potential Cation Channels in Cancer Therapy.|pdf=|usr=}}{{31801263}}
{{tp|p=29537902|t=2018. Urinary Magnesium and Other Elements in Relation to Mammographic Breast Density, a Measure of Breast Cancer Risk.|pdf=|usr=}}{{29537902}}
{{tp|p=34312420|t=2021. Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients.|pdf=|usr=}}
{{tp|p=33923895|t=2021. Assessment and Imaging of Intracellular Magnesium in SaOS-2 Osteosarcoma Cells and Its Role in Proliferation.|pdf=|usr=}}{{33923895}}
{{tp|p=33450887|t=2021. Mg(2+) Transporters in Digestive Cancers.|pdf=|usr=}}{{33450887}}
{{tp|p=29772843|t=2018. The Role of TRP Channels in the Metastatic Cascade.|pdf=|usr=}}{{29772843}}
{{tp|p=34938893|t=2021. Oral magnesium supplements for cancer treatment-induced hypomagnesemia: Results from a pilot randomized trial.|pdf=|usr=}}{{34938893}}
{{tp|p=25343568|t=2015. EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: attenuation by NK-1 receptor blockade.|pdf=|usr=}}{{25343568}}
{{tp|p=20595681|t=2010. Effects of the EGFR Inhibitor Erlotinib on Magnesium Handling.|pdf=|usr=}}{{20595681}}
{{tp|p=C3046074|t=2011. A role for Trpm7 in pancreatic cancer?|pdf=|usr=}}{{C3046074}}
{{tp|p=C7650375|t=2020. CSIG-13. TRPM7 INDUCES TUMORIGENESIS AND STEMNESS THROUGH NOTCH ACTIVATION IN GLIOMA.|pdf=|usr=}}{{C7650375}}
{{tp|p=C6847576|t=2019. CSIG-05. TRPM7 INDUCES MECHANISTIC TARGET OF Rap1b THROUGH DOWNREGULATION OF miR-28-5p IN GLIOMA PROLIFERATION AND INVASION.|pdf=|usr=}}{{C6847576}}
{{tp|p=34149438|t=2021. Editorial: Ion Channel Signalling in Cancer: From Molecular Mechanisms to Therapeutics.|pdf=|usr=}}{{34149438}}
{{tp|p=27688901|t=2016. Correlation between blood magnesium and calcium concentration in patients treated with an anti-EGFR antibody.|pdf=|usr=}}{{27688901}}
{{tp|p=33726758|t=2021. O-GlcNAcylation homeostasis controlled by calcium influx channels regulates multiple myeloma dissemination.|pdf=|usr=}}{{33726758}}
{{tp|p=33210606|t=2020. Magnesium deficiency with high calcium-to-magnesium ratio promotes a metastatic phenotype in the CT26 colon cancer cell line.|pdf=|usr=}}{{33210606}}
{{tp|p=34067290|t=2021. A Comparison of Doxorubicin-Resistant Colon Cancer LoVo and Leukemia HL60 Cells: Common Features, Different Underlying Mechanisms.|pdf=|usr=}}{{34067290}}
{{tp|p=35053440|t=2022. Canine Oral Melanoma Genomic and Transcriptomic Study Defines Two Molecular Subgroups with Different Therapeutical Targets.|pdf=|usr=}}{{35053440}}
{{tp|p=33132914|t=2020. TRP Channels and Small GTPases Interplay in the Main Hallmarks of Metastatic Cancer.|pdf=|usr=}}{{33132914}}
{{tp|p=32948812|t=2021. Ascorbate-induced oxidative stress mediates TRP channel activation and cytotoxicity in human etoposide-sensitive and -resistant retinoblastoma cells.|pdf=|usr=}}{{32948812}}
{{tp|p=31834994|t=2019. Intracellular Ion Channels in Pancreas Cancer.|pdf=|usr=}}{{31834994}}
{{tp|p=30997980|t=2019. Is there any difference between endometrial hyperplasia and endometrial carcinoma in terms of expression of TRPM2 and TRPM7 ion channels?|pdf=|usr=}}{{30997980}}
{{tp|p=30679450|t=2019. Deposition of calcium in an in vitro model of human breast tumour calcification reveals functional role for ALP activity, altered expression of osteogenic genes and dysregulation of the TRPM7 ion channel.|pdf=|usr=}}{{30679450}}
{{tp|p=30477473|t=2018. TRPM7 overexpression enhances the cancer stem cell-like and metastatic phenotypes of lung cancer through modulation of the Hsp90alpha/uPA/MMP2 signaling pathway.|pdf=|usr=}}{{30477473}}
{{tp|p=30134548|t=2018. Functional Expression of TRP Ion Channels in Endometrial Stromal Cells of Endometriosis Patients.|pdf=|usr=}}{{30134548}}
{{tp|p=30033625|t=2018. TRPM7-mediated spontaneous Ca(2+) entry regulates the proliferation and differentiation of human leukemia cell line K562.|pdf=|usr=}}{{30033625}}
{{tp|p=29949888|t=2018. Carbonate Apatite Nanoparticles-Facilitated Intracellular Delivery of siRNA(s) Targeting Calcium Ion Channels Efficiently Kills Breast Cancer Cells.|pdf=|usr=}}{{29949888}}
{{tp|p=29299124|t=2017. FTY-720 induces apoptosis in neuroblastoma via multiple signaling pathways.|pdf=|usr=}}{{29299124}}
{{tp|p=27033800|t=2016. [TRPM7 and tumor].|pdf=|usr=}}{{27033800}}
{{tp|p=31646523|t=2020. Calcium Signaling and the Regulation of Chemosensitivity in Cancer Cells: Role of the Transient Receptor Potential Channels.|pdf=|usr=}}{{31646523}}
{{tp|p=31279156|t=2019. TRP channels in gastric cancer: New hopes and clinical perspectives.|pdf=|usr=}}{{31279156}}
{{tp|p=25820697|t=2015. Functional expression of transient receptor potential channels in human endometrial stromal cells during the luteal phase of the menstrual cycle.|pdf=|usr=}}{{25820697}}
{{tp|p=25666946|t=2015. A role for calcium in the regulation of ATP-binding cassette, sub-family C, member 3 (ABCC3) gene expression in a model of epidermal growth factor-mediated breast cancer epithelial-mesenchymal transition.|pdf=|usr=}}{{25666946}}
{{tp|p=28119804|t=2017. Targeting calcium signaling in cancer therapy.|pdf=|usr=}}{{28119804}}
{{tp|p=26446806|t=2015. Dietary magnesium: the magic mineral that protects from colon cancer?|pdf=|usr=}}{{26446806}}
{{tp|p=26333203|t=2016. Calcium/magnesium intake ratio, but not magnesium intake, interacts with genetic polymorphism in relation to colorectal neoplasia in a two-phase study.|pdf=|usr=}}{{26333203}}
{{tp|p=26072287|t=2015. Plasma membrane calcium channels in cancer: Alterations and consequences for cell proliferation and migration.|pdf=|usr=}}{{26072287}}
{{tp|p=22135214|t=2012. Constitutive expression of a Mg2+-inhibited K+ current and a TRPM7-like current in human erythroleukemia cells.|pdf=|usr=}}{{22135214}}
{{tp|p=38126996|t=2023. Acetylshikonin induces necroptosis via the RIPK1/RIPK3-dependent pathway in lung cancer.|pdf=|usr=}}{{38126996}}
{{tp|p=37509428|t=2023. Colorectal Cancer Cell Invasion and Functional Properties Depend on Peri-Tumoral Extracellular Matrix.|pdf=|usr=}}{{37509428}}
{{tp|p=37189782|t=2023. The Emergence of TRP Channels Interactome as a Potential Therapeutic Target in Pancreatic Ductal Adenocarcinoma.|pdf=|usr=}}{{37189782}}
{{tp|p=36551219|t=2022. Substrate Type and Concentration Differently Affect Colon Cancer Cells Ultrastructural Morphology, EMT Markers, and Matrix Degrading Enzymes.|pdf=|usr=}}{{36551219}}
{{tp|p=36313195|t=2022. Gastrulation Screening to Identify Anti-metastasis Drugs in Zebrafish Embryos.|pdf=|usr=}}{{36313195}}
{{tp|p=35625809|t=2022. The Role of the Metabolism of Zinc and Manganese Ions in Human Cancerogenesis.|pdf=|usr=}}{{35625809}}
{{tp|p=35517894|t=2022. Curcumin Prevents Epithelial-to Mesenchymal Transition-Mediated Ovarian Cancer Progression through NRF2/ETBR/ET-1 Axis and Preserves Mitochondria Biogenesis in Kidney after Cisplatin Administration.|pdf=|usr=}}{{35517894}}
{{tp|p=35416125|t=2022. Oncogenic magnesium transporter 1 upregulates programmed death-1-ligand 1 expression and contributes to growth and radioresistance of glioma cells through the ERK/MAPK signaling pathway.|pdf=|usr=}}{{35416125}}
{{tp|p=35224300|t=2022. Self-anti-angiogenesis nanoparticles enhance anti-metastatic-tumor efficacy of chemotherapeutics.|pdf=|usr=}}{{35224300}}
{{tp|p=34854917|t=2021. Spatiotemporal regulation of store-operated calcium entry in cancer metastasis.|pdf=|usr=}}{{34854917}}
{{tp|p=34572386|t=2021. Role of Calcium Homeostasis in Modulating EMT in Cancer.|pdf=|usr=}}{{34572386}}
{{tp|p=33686021|t=2021. BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma.|pdf=|usr=}}{{33686021}}
{{tp|p=32668414|t=2020. CircRNA FGFR3 induces epithelial-mesenchymal transition of ovarian cancer by regulating miR-29a-3p/E2F1 axis.|pdf=|usr=}}{{32668414}}
{{tp|p=31076559|t=2019. Magnesium transporter protein solute carrier family 41 member 1 suppresses human pancreatic ductal adenocarcinoma through magnesium-dependent Akt/mTOR inhibition and bax-associated mitochondrial apoptosis.|pdf=|usr=}}{{31076559}}
{{tp|p=27721658|t=2016. Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins.|pdf=|usr=}}{{27721658}}
{{tp|p=25710007|t=2015. Calcium channel expression and applicability as targeted therapies in melanoma.|pdf=|usr=}}{{25710007}}
{{tp|p=23903698|t=2013. Role of coagulation in the recruitment of colon adenocarcinoma cells to thrombus under shear.|pdf=|usr=}}{{23903698}}
{{tp|p=23021240|t=2012. Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes.|pdf=|usr=}}{{23021240}}
{{tp|p=37345095|t=2023. Inhibitory Potential of Resveratrol in Cancer Metastasis: From Biology to Therapy.|pdf=|usr=}}{{37345095}}
{{tp|p=35773608|t=2022. EWI2 prevents EGFR from clustering and endocytosis to reduce tumor cell movement and proliferation.|pdf=|usr=}}{{35773608}}
{{tp|p=35443626|t=2022. Computationally repurposing drugs for breast cancer subtypes using a network-based approach.|pdf=|usr=}}{{35443626}}
{{tp|p=35239002|t=2022. Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens.|pdf=|usr=}}{{35239002}}
{{tp|p=34831037|t=2021. Channeling the Force: Piezo1 Mechanotransduction in Cancer Metastasis.|pdf=|usr=}}{{34831037}}
{{tp|p=34800629|t=2022. O-GlcNAcylation regulation of cellular signaling in cancer.|pdf=|usr=}}{{34800629}}
Migration and Cancer Metastasis.|pdf=|usr=}}{{34069353}}
{{tp|p=34066059|t=2021. Upregulation of Chemoresistance by Mg(2+) Deficiency through Elevation of ATP Binding Cassette Subfamily B Member 1 Expression in Human Lung Adenocarcinoma A549 Cells.|pdf=|usr=}}{{34066059}}
{{tp|p=32825277|t=2020. Targeting the Calcium Signalling Machinery in Cancer.|pdf=|usr=}}{{32825277}}
{{tp|p=32649885|t=2020. Oxidative Stress in Cancer.|pdf=|usr=}}{{32649885}}
{{tp|p=32503141|t=2020. The Mechanical Microenvironment in Breast Cancer.|pdf=|usr=}}{{32503141}}
{{tp|p=31120184|t=2019. Cell volume regulation in cancer cell migration driven by osmotic water flow.|pdf=|usr=}}{{31120184}}
{{tp|p=30683840|t=2019. CK2 inhibition with silmitasertib promotes methuosis-like cell death associated to catastrophic massive vacuolization of colorectal cancer cells.|pdf=|usr=}}{{30683840}}
{{tp|p=30315244|t=2018. CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1alpha.|pdf=|usr=}}{{30315244}}
{{tp|p=29636894|t=2018. A temporal examination of calcium signaling in cancer- from tumorigenesis, to immune evasion, and metastasis.|pdf=|usr=}}{{29636894}}
{{tp|p=28841204|t=2017. From Waldenstrom's macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation.|pdf=|usr=}}{{28841204}}
{{tp|p=28143649|t=2017. Crosstalk between calcium and reactive oxygen species signaling in cancer.|pdf=|usr=}}{{28143649}}
{{tp|p=24004445|t=2013. Acidic extracellular microenvironment and cancer.|pdf=|usr=}}{{24004445}}
{{tp|p=19549916|t=2009. Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease.|pdf=|usr=}}{{19549916}}
{{tp|p=37600653|t=2023. The implication of necroptosis-related lncRNAs in orchestrating immune infiltration and predicting therapeutic efficacy in colon adenocarcinoma: an integrated bioinformatic analysis with preliminarily experimental validation.|pdf=|usr=}}{{37600653}}
{{tp|p=37456663|t=2023. Long non-coding RNAs in non-small cell lung cancer: implications for EGFR-TKI resistance.|pdf=|usr=}}{{37456663}}
{{tp|p=35391801|t=2022. Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions.|pdf=|usr=}}{{35391801}}
{{tp|p=35252173|t=2022. Environmental Cadmium Exposure Promotes the Development, Progression and Chemoradioresistance of Esophageal Squamous Cell Carcinoma.|pdf=|usr=}}{{35252173}}
{{tp|p=34458247|t=2021. Transient Receptor Potential (TRP) Ion Channels Involved in Malignant Glioma Cell Death and Therapeutic Perspectives.|pdf=|usr=}}{{34458247}}
{{tp|p=34149360|t=2021. Mechanisms of Invasion in Glioblastoma: Extracellular Matrix, Ca(2+) Signaling, and Glutamate.|pdf=|usr=}}{{34149360}}
{{tp|p=36046434|t=2021. Targeting cytoskeletal phosphorylation in cancer.|pdf=|usr=}}{{36046434}}
{{tp|p=36046433|t=2021. Advances in the study of cancer metastasis and calcium signaling as potential therapeutic targets.|pdf=|usr=}}{{36046433}}
{{tp|p=27814637|t=2017. Zinc transporters and dysregulated channels in cancers.|pdf=|usr=}}{{27814637}}
{{tp|p=38090580|t=2023. Research progress on the mechanism of glycolysis in ovarian cancer.|pdf=|usr=}}{{38090580}}
{{tp|p=37670938|t=2023. A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma.|pdf=|usr=}}{{37670938}}
{{tp|p=37664034|t=2023. The effects of statins in patients with advanced-stage cancers - a systematic review and meta-analysis.|pdf=|usr=}}{{37664034}}
{{tp|p=37389120|t=2023. Tumour associated endothelial cells: origin, characteristics and role in metastasis and anti-angiogenic resistance.|pdf=|usr=}}{{37389120}}
{{tp|p=37033630|t=2023. Therapeutic potential of TRPM8 channels in cancer treatment.|pdf=|usr=}}{{37033630}}
{{tp|p=36591215|t=2022. A transient receptor potential channel-related model based on machine learning for evaluating tumor microenvironment and immunotherapeutic strategies in acute myeloid leukemia.|pdf=|usr=}}{{36591215}}
{{tp|p=36389750|t=2022. Comprehensive analysis of transient receptor potential channels-related signature for prognosis, tumor immune microenvironment, and treatment response of colorectal cancer.|pdf=|usr=}}{{36389750}}
{{tp|p=36313365|t=2022. Research progress of ginseng in the treatment of gastrointestinal cancers.|pdf=|usr=}}{{36313365}}
{{tp|p=36189275|t=2022. A risk signature based on necroptotic-process-related genes predicts prognosis and immune therapy response in kidney cell carcinoma.|pdf=|usr=}}{{36189275}}
{{tp|p=36091124|t=2022. Integrated analysis of the M2 macrophage-related signature associated with prognosis in ovarian cancer.|pdf=|usr=}}{{36091124}}
{{tp|p=36046825|t=2022. The Role and Therapeutic Potential of Macropinocytosis in Cancer.|pdf=|usr=}}{{36046825}}
{{tp|p=36033489|t=2022. The modulation of ion channels in cancer chemo-resistance.|pdf=|usr=}}{{36033489}}
{{tp|p=35646635|t=2022. Analysis of PANoptosis-Related LncRNA-miRNA-mRNA Network Reveals LncRNA SNHG7 Involved in Chemo-Resistance in Colon Adenocarcinoma.|pdf=|usr=}}{{35646635}}
{{tp|p=35493463|t=2022. The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response.|pdf=|usr=}}{{35493463}}
{{tp|p=35127517|t=2021. Mechanical Properties in the Glioma Microenvironment: Emerging Insights and Theranostic Opportunities.|pdf=|usr=}}{{35127517}}
{{tp|p=34988012|t=2021. Alterations of Ion Homeostasis in Cancer Metastasis: Implications for Treatment.|pdf=|usr=}}{{34988012}}
{{tp|p=34737957|t=2021. Targeting Sphingolipids for Cancer Therapy.|pdf=|usr=}}{{34737957}}
{{tp|p=34540702|t=2021. Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins.|pdf=|usr=}}{{34540702}}
{{tp|p=34122115|t=2021. Development of Store-Operated Calcium Entry-Targeted Compounds in Cancer.|pdf=|usr=}}{{34122115}}
{{tp|p=33968752|t=2021. Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer.|pdf=|usr=}}{{33968752}}
{{tp|p=33777808|t=2021. Roles of Non-Coding RNAs in Cervical Cancer Metastasis.|pdf=|usr=}}{{33777808}}
{{tp|p=33542897|t=2020. The Dual Role of Macropinocytosis in Cancers: Promoting Growth and Inducing Methuosis to Participate in Anticancer Therapies as Targets.|pdf=|usr=}}{{33542897}}
{{tp|p=33344232|t=2020. Transient Receptor Potential Melastatin 8 (TRPM8) Channel Regulates Proliferation and Migration of Breast Cancer Cells by Activating the AMPK-ULK1 Pathway to Enhance Basal Autophagy.|pdf=|usr=}}{{33344232}}
{{tp|p=32211326|t=2020. Calcium Homeostasis: A Potential Vicious Cycle of Bone Metastasis in Breast Cancers.|pdf=|usr=}}{{32211326}}
{{tp|p=31275168|t=2019. A TR(i)P to Cell Migration: New Roles of TRP Channels in Mechanotransduction and Cancer.|pdf=|usr=}}{{31275168}}
{{tp|p=31110513|t=2019. Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and Processes.|pdf=|usr=}}{{31110513}}
{{tp|p=30250825|t=2018. Transforming Growth Factor-beta-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis.|pdf=|usr=}}{{30250825}}
{{tp|p=28848710|t=2017. The Regulation of Tumor Cell Invasion and Metastasis by Endoplasmic Reticulum-to-Mitochondrial Ca(2+) Transfer.|pdf=|usr=}}{{28848710}}
{{tp|p=28824873|t=2017. Functional Assay of Cancer Cell Invasion Potential Based on Mechanotransduction of Focused Ultrasound.|pdf=|usr=}}{{28824873}}
{{tp|p=37928877|t=2023. The Structural Proteins of Membrane Rafts, Caveolins and Flotillins, in Lung Cancer: More Than Just Scaffold Elements.|pdf=|usr=}}{{37928877}}
{{tp|p=37762011|t=2023. Mechanosensitive Ion Channels: Their Physiological Importance and Potential Key Role in Cancer.|pdf=|usr=}}{{37762011}}
{{tp|p=36835147|t=2023. Whole-Genome Duplication and Genome Instability in Cancer Cells: Double the Trouble.|pdf=|usr=}}{{36835147}}
{{tp|p=35886072|t=2022. The Epitranscriptome in miRNAs: Crosstalk, Detection, and Function in Cancer.|pdf=|usr=}}{{35886072}}
{{tp|p=35806388|t=2022. Ca(2+) Signalling and Hypoxia/Acidic Tumour Microenvironment Interplay in Tumour Progression.|pdf=|usr=}}{{35806388}}
{{tp|p=34209733|t=2021. Store-Independent Calcium Entry and Related Signaling Pathways in Breast Cancer.|pdf=|usr=}}{{34209733}}
{{tp|p=33801659|t=2021. PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects.|pdf=|usr=}}{{33801659}}
{{tp|p=35782985|t=2022. Mechanism and effect of stress granule formation in cancer and its potential roles in breast cancer therapy.|pdf=|usr=}}{{35782985}}
{{tp|p=33374380|t=2020. Molecular Aspects and Prognostic Significance of Microcalcifications in Human Pathology: A Narrative Review.|pdf=|usr=}}{{33374380}}
{{tp|p=32549750|t=2020. Mechanical tumor microenvironment and transduction: cytoskeleton mediates cancer cell invasion and metastasis.|pdf=|usr=}}{{32549750}}
{{tp|p=31991573|t=2020. The Role of Calmodulin in Tumor Cell Migration, Invasiveness, and Metastasis.|pdf=|usr=}}{{31991573}}
{{tp|p=31718020|t=2019. Microcalcifications Drive Breast Cancer Occurrence and Development by Macrophage-Mediated Epithelial to Mesenchymal Transition.|pdf=|usr=}}{{31718020}}
{{tp|p=30011966|t=2018. Targeting Mitochondrial Ion Channels to Fight Cancer.|pdf=|usr=}}{{30011966}}
{{tp|p=24204345|t=2013. Emerging role of TRP channels in cell migration: from tumor vascularization to metastasis.|pdf=|usr=}}{{24204345}}
{{tp|p=24106480|t=2013. Calcium-permeable ion channels in control of autophagy and cancer.|pdf=|usr=}}{{24106480}}
{{tp|p=37838167|t=2023. On a sugar high: Role of O-GlcNAcylation in cancer.|pdf=|usr=}}{{37838167}}
{{tp|p=37553567|t=2023. Macrophage-organoid co-culture model for identifying treatment strategies against macrophage-related gemcitabine resistance.|pdf=|usr=}}{{37553567}}
{{tp|p=37431884|t=2023. Oridonin suppresses gastric cancer SGC-7901 cell proliferation by targeting the TNF-alpha/androgen receptor/TGF-beta signalling pathway axis.|pdf=|usr=}}{{37431884}}
{{tp|p=35510498|t=2022. Fluid shear stress regulates the survival of circulating tumor cells via nuclear expansion.|pdf=|usr=}}{{35510498}}
{{tp|p=35366054|t=2022. Polycystins, mechanotransduction and cancer development.|pdf=|usr=}}{{35366054}}
{{tp|p=35274124|t=2022. Piezo1 activation attenuates thrombin-induced blebbing in breast cancer cells.|pdf=|usr=}}{{35274124}}
{{tp|p=28922779|t=2018. Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4.|pdf=|usr=}}{{28922779}}
{{tp|p=28304082|t=2017. Molecular mechanisms of tumour invasion: regulation by calcium signals.|pdf=|usr=}}{{28304082}}
{{tp|p=27761377|t=2016. The role of extracellular calcium in bone metastasis.|pdf=|usr=}}{{27761377}}
{{tp|p=27716384|t=2016. Ion channels expression and function are strongly modified in solid tumors and vascular malformations.|pdf=|usr=}}{{27716384}}
{{tp|p=25404747|t=2014. STIM1- and Orai1-mediated Ca(2+) oscillation orchestrates invadopodium formation and melanoma invasion.|pdf=|usr=}}{{25404747}}
{{tp|p=25391657|t=2014. A splice variant of the human ion channel TRPM2 modulates neuroblastoma tumor growth through hypoxia-inducible factor (HIF)-1/2alpha.|pdf=|usr=}}{{25391657}}
{{tp|p=22822055|t=2012. Calcium channels and pumps in cancer: changes and consequences.|pdf=|usr=}}{{22822055}}
{{tp|p=22131816|t=2011. Safety and clinical usage of newcastle disease virus in cancer therapy.|pdf=|usr=}}{{22131816}}
{{tp|p=21253548|t=2011. Survivin selectively modulates genes deregulated in human leukemia stem cells.|pdf=|usr=}}{{21253548}}
{{tp|p=37864030|t=2023. Biophysics in tumor growth and progression: from single mechano-sensitive molecules to mechanomedicine.|pdf=|usr=}}{{37864030}}
{{tp|p=36906534|t=2023. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments.|pdf=|usr=}}{{36906534}}
{{tp|p=36797764|t=2023. Transfer RNA-derived small RNAs in tumor microenvironment.|pdf=|usr=}}{{36797764}}
{{tp|p=36591597|t=2023. The roles of long nonâ€‘coding RNAs in renal cell carcinoma (Review).|pdf=|usr=}}{{36591597}}
{{tp|p=35455071|t=2022. Galvanotactic Migration of Glioblastoma and Brain Metastases Cells.|pdf=|usr=}}{{35455071}}
{{tp|p=34117364|t=2021. A time-course Raman spectroscopic analysis of spontaneous in vitro microcalcifications in a breast cancer cell line.|pdf=|usr=}}{{34117364}}
{{tp|p=28264681|t=2017. Ion channels or aquaporins as novel molecular targets in gastric cancer.|pdf=|usr=}}{{28264681}}
{{tp|p=28209759|t=2017. Revisiting Seed and Soil: Examining the Primary Tumor and Cancer Cell Foraging in Metastasis.|pdf=|usr=}}{{28209759}}
{{tp|p=26503475|t=2016. The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer.|pdf=|usr=}}{{26503475}}
{{tp|p=24080946|t=2014. Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy.|pdf=|usr=}}{{24080946}}
{{tp|p=23736792|t=2013. Indomethacin inhibits cancer cell migration via attenuation of cellular calcium mobilization.|pdf=|usr=}}{{23736792}}
{{tp|p=23515871|t=2013. STIM1 and Orai1 mediate CRAC channel activity and are essential for human glioblastoma invasion.|pdf=|usr=}}{{23515871}}
{{tp|p=18800146|t=2009. Targeting the leukemic stem cell: the Holy Grail of leukemia therapy.|pdf=|usr=}}{{18800146}}
{{tp|p=37291276|t=2023. Microcalcification crystallography as a potential marker of DCIS recurrence.|pdf=|usr=}}{{37291276}}
{{tp|p=35116652|t=2021. Lidocaine inhibits the proliferation and metastasis of epithelial ovarian cancer through the Wnt/beta-catenin pathway.|pdf=|usr=}}{{35116652}}
{{tp|p=33335095|t=2020. Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy.|pdf=|usr=}}{{33335095}}
{{tp|p=32691369|t=2020. Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics.|pdf=|usr=}}{{32691369}}
{{tp|p=26670335|t=2015. Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer.|pdf=|usr=}}{{26670335}}
{{tp|p=32272952|t=2020. Long noncoding RNAs involvement in Epstein-Barr virus infection and tumorigenesis.|pdf=|usr=}}{{32272952}}
{{tp|p=25542231|t=2015. Electrolyte disorders assessment in solid tumor patients treated with anti-EGFR monoclonal antibodies: a pooled analysis of 25 randomized clinical trials.|pdf=|usr=}}{{25542231}}
{{tp|p=35779873|t=2022. Chemotherapy induced gastrointestinal toxicities.|pdf=|usr=}}{{35779873}}
{{tp|p=34440090|t=2021. Bioactive Compounds with Antiglioma Activity from Marine Species.|pdf=|usr=}}{{34440090}}
{{tp|p=32723565|t=2020. Ca(2+) as a therapeutic target in cancer.|pdf=|usr=}}{{32723565}}
{{tp|p=28560064|t=2017. Fms related tyrosine kinase 1 (Flt1) functions as an oncogene and regulates glioblastoma cell metastasis by regulating sonic hedgehog signaling.|pdf=|usr=}}{{28560064}}
{{tp|p=28119804|t=2017. Targeting calcium signaling in cancer therapy.|pdf=|usr=}}{{28119804}}
{{tp|p=31088826|t=2019. The Calcium-Signaling Toolkit in Cancer: Remodeling and Targeting.|pdf=|usr=}}{{31088826}}
{{tp|p=28600336|t=2017. Diagnosis and classification of hematologic malignancies on the basis of genetics.|pdf=|usr=}}{{28600336}}
{{tp|p=27702801|t=2016. LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis.|pdf=|usr=}}{{27702801}}
{{tp|p=24322982|t=2014. Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination.|pdf=|usr=}}{{24322982}}
{{tp|p=38201302|t=2024. Extracellular Matrix Cues Regulate Mechanosensing and Mechanotransduction of Cancer Cells.|pdf=|usr=}}{{38201302}}
{{tp|p=37037673|t=2023. Role of extrinsic physical cues in cancer progression.|pdf=|usr=}}{{37037673}}
{{tp|p=36396822|t=2023. Evolving roles of CD38 metabolism in solid tumour microenvironment.|pdf=|usr=}}{{36396822}}
{{tp|p=36066649|t=2023. Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors.|pdf=|usr=}}{{36066649}}
{{tp|p=35454894|t=2022. Treatment of Neuropathic Pain Directly Due to Cancer: An Update.|pdf=|usr=}}{{35454894}}
{{tp|p=34949672|t=2022. Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy.|pdf=|usr=}}{{34949672}}
{{ttp|p=32443774|t=2020. The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives.|pdf=|usr=}}{{32443774}}
{{tp|p=32249682|t=2020. Cannabinoids as anticancer therapeutic agents.|pdf=|usr=}}{{32249682}}
{{tp|p=28730291|t=2017. Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management.|pdf=|usr=}}{{28730291}}
{{tp|p=25987988|t=2015. Acidic microenvironment and bone pain in cancer-colonized bone.|pdf=|usr=}}{{25987988}}
{{tp|p=37664239|t=2023. Ion channels in cancer-induced bone pain: from molecular mechanisms to clinical applications.|pdf=|usr=}}{{37664239}}
{{tp|p=35847920|t=2022. Comprehensive Pan-Cancer Analysis of TRPM8 in Tumor Metabolism and Immune Escape.|pdf=|usr=}}{{35847920}}
{{tp|p=34345027|t=2022. Paraneoplastic ocular syndrome: a pandora's box of underlying malignancies.|pdf=|usr=}}{{34345027}}
{{tp|p=28620280|t=2017. Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.|pdf=|usr=}}{{28620280}}
{{tp|p=27289382|t=2016. Impact of intracellular ion channels on cancer development and progression.|pdf=|usr=}}{{27289382}}
{{tp|p=35207698|t=2022. Ion Channel Involvement in Tumor Drug Resistance.|pdf=|usr=}}{{35207698}}
{{tp|p=34850897|t=2021. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids.|pdf=|usr=}}{{34850897}}
{{tp|p=33715811|t=2020. Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts.|pdf=|usr=}}{{33715811}}
{{tp|p=29777637|t=2018. Thymol inhibits oral squamous cell carcinoma growth via mitochondria-mediated apoptosis.|pdf=|usr=}}{{29777637}}
{{tp|p=36866769|t=2023. The Hedgehog/GLI signaling pathway activates transcription of Slug (Snail2) in melanoma cells.|pdf=|usr=}}{{36866769}}
{{tp|p=33802144|t=2021. Peppers: A "Hot" Natural Source for Antitumor Compounds.|pdf=|usr=}}{{33802144}}
{{tp|p=31441200|t=2019. TRPM4 is highly expressed in human colorectal tumor buds and contributes to proliferation, cell cycle, and invasion of colorectal cancer cells.|pdf=|usr=}}{{31441200}}
{{tp|p=29541177|t=2018. RNA interference-mediated depletion of TRPM8 enhances the efficacy of epirubicin chemotherapy in prostate cancer LNCaP and PC3 cells.|pdf=|usr=}}{{29541177}}
{{tp|p=28039451|t=2017. High-throughput proteome analysis reveals targeted TRPM8 degradation in prostate cancer.|pdf=|usr=}}{{28039451}}
{{tp|p=27852311|t=2016. Caveolin-1 in the regulation of cell metabolism: a cancer perspective.|pdf=|usr=}}{{27852311}}
{{tp|p=29318210|t=2017. Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative Review.|pdf=|usr=}}{{29318210}}
{{tp|p=26870186|t=2016. Anti-tumor activity of the TRPM8 inhibitor BCTC in prostate cancer DU145 cells.|pdf=|usr=}}{{26870186}}
{{tp|p=24583980|t=2014. beta-Lapachone ameliorates murine cisplatin nephrotoxicity: NAD(+), NQO1, and SIRT1 at the crossroads of metabolism, injury, and inflammation.|pdf=|usr=}}{{24583980}}
{{tp|p=24053997|t=2013. Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach.|pdf=|usr=}}{{24053997}}
{{tp|p=34147842|t=2021. Compensatory expression of NRF2-dependent antioxidant genes is required to overcome the lethal effects of Kv11.1 activation in breast cancer cells and PDOs.|pdf=|usr=}}{{34147842}}
{{tp|p=32823168|t=2020. Formononetin ameliorates oxaliplatin-induced peripheral neuropathy via the KEAP1-NRF2-GSTP1 axis.|pdf=|usr=}}{{32823168}}
{{tp|p=32324760|t=2020. Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy.|pdf=|usr=}}{{32324760}}
{{tp|p=31780732|t=2019. Curcumin enhances cisplatin-induced human laryngeal squamous cancer cell death through activation of TRPM2 channel and mitochondrial oxidative stress.|pdf=|usr=}}{{31780732}}